Head-to-head comparisons of the neutralizing antibody against SARS-CoV-2 variants elicited by four priming-boosting regimens

por Jiang, Hu-Dachuan, Guo, Xi-ling, Jin, Peng-Fei, Tang, Rong, Li, Jing-Xin, Zhu, Feng-Cai
Publicado 2022

Experimental infections of mosquitoes with severe fever with thrombocytopenia syndrome virus

por Liang, Shu-Yi, Chu, Hong-Liang, Guo, Xi-Ling, Wang, Wei, Chen, Hong-Na, Zhang, Yu-Fu, Chen, Yin, Wu, Tao, Bao, Chang-Jun, Zhou, Ming-Hao
Publicado 2017

Outbreak of Vaccinia Virus Infection from Occupational Exposure, China, 2017

por Lu, Bing, Cui, Lun-Biao, Gu, Min-Hua, Shi, Chao, Sun, Chuan-Wu, Zhao, Kang-Chen, Bi, Jun, Tan, Zhong-Ming, Guo, Xi-Ling, Huo, Xiang, Bao, Chang-Jun
Publicado 2019

Probable person to person transmission of novel avian influenza A (H7N9) virus in Eastern China, 2013: epidemiological investigation

por Qi, Xian, Qian, Yan-Hua, Bao, Chang-Jun, Guo, Xi-Ling, Cui, Lun-Biao, Tang, Fen-Yang, Ji, Hong, Huang, Yong, Cai, Pei-Quan, Lu, Bing, Xu, Ke, Shi, Chao, Zhu, Feng-Cai, Zhou, Ming-Hao, Wang, Hua
Publicado 2013

Safety and immunogenicity of heterologous boost immunisation with an orally administered aerosolised Ad5-nCoV after two-dose priming with an inactivated SARS-CoV-2 vaccine in Chine...

por Li, Jing-Xin, Wu, Shi-Po, Guo, Xi-Ling, Tang, Rong, Huang, Bao-Ying, Chen, Xiao-Qin, Chen, Yin, Hou, Li-Hua, Liu, Jing-Xian, Zhong, Jin, Pan, Hong-Xing, Shi, Feng-Juan, Xu, Xiao-Yu, Li, Zhuo-Pei, Zhang, Xiao-Yin, Cui, Lun-Biao, Tan, Wen-Jie, Chen, Wei, Zhu, Feng-Cai
Publicado 2022

Safety and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older: two single-center, randomised, double-blind, placebo-controlle...

por Meng, Fan-Yue, Gao, Fan, Jia, Si-Yue, Wu, Xiang-Hong, Li, Jing-Xin, Guo, Xi-Ling, Zhang, Jia-Lu, Cui, Bo-Pei, Wu, Zhi-Ming, Wei, Ming-Wei, Ma, Zhi-Long, Peng, Hai-Lin, Pan, Hong-Xing, Fan, Lin, Zhang, Jing, Wan, Jiu-Qin, Zhu, Zhong-Kui, Wang, Xue-Wen, Zhu, Feng-Cai
Publicado 2021

Safety and immunogenicity of aerosolised Ad5-nCoV, intramuscular Ad5-nCoV, or inactivated COVID-19 vaccine CoronaVac given as the second booster following three doses of CoronaVac:...

por Tang, Rong, Zheng, Hui, Wang, Bu-Sen, Gou, Jin-Bo, Guo, Xi-Ling, Chen, Xiao-Qin, Chen, Yin, Wu, Shi-Po, Zhong, Jin, Pan, Hong-Xing, Zhu, Jia-Hong, Xu, Xiao-Yu, Shi, Feng-Juan, Li, Zhuo-Pei, Liu, Jing-Xian, Zhang, Xiao-Yin, Cui, Lun-Biao, Song, Zhi-Zhou, Hou, Li-Hua, Zhu, Feng-Cai, Li, Jing-Xin
Publicado 2023

Immunogenicity and safety of heterologous immunisation with Ad5-nCOV in healthy adults aged 60 years and older primed with an inactivated SARS-CoV-2 vaccine (CoronaVac): a phase 4,...

por Jin, Peng-Fei, Guo, Xi-Ling, Gou, Jin-Bo, Hou, Li-Hua, Song, Zhi-Zhou, Zhu, Tao, Pan, Hong-Xing, Zhu, Jia-Hong, Shi, Feng-Juan, Du, Pan, Huang, Hai-Tao, Liu, Jing-Xian, Zheng, Hui, Wang, Xue, Chen, Yin, Wan, Peng, Wu, Shi-Po, Wang, Xue-Wen, Xu, Xiao-Yu, Yan, Fang-Rong, Li, Jing-Xin, Chen, Wei, Zhu, Feng-Cai
Publicado 2023

A proof of concept for neutralizing antibody-guided vaccine design against SARS-CoV-2

por Zhang, Li, Cao, Lei, Gao, Xing-Su, Zheng, Bin-Yang, Deng, Yong-Qiang, Li, Jing-Xin, Feng, Rui, Bian, Qian, Guo, Xi-Ling, Wang, Nan, Qiu, Hong-Ying, Wang, Lei, Cui, Zhen, Ye, Qing, Chen, Geng, Lu, Kui-Kui, Chen, Yin, Chen, Yu-Tao, Pan, Hong-Xing, Yu, Jiaping, Yao, Wenrong, Zhu, Bao-Li, Chen, Jianping, Liu, Yong, Qin, Cheng-Feng, Wang, Xiangxi, Zhu, Feng-Cai
Publicado 2021